Activating NRF2E79Q mutation alters the differentiation of human non-small cell lung cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• The NRF2 signaling pathway is implicated in tumor initiation, progression, and treatment resistance in various cancers.
• NRF2-active tumors exhibit altered metabolism, redox state, and immune evasion.
• Understanding NRF2's role in non-small cell lung cancer (NSCLC) is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the molecular and phenotypic effects of NRF2 activation in two distinct human NSCLC cell models.
• To determine how NRF2 activation influences tumor growth, cellular morphology, and gene expression in NSCLC.
• To identify context-dependent NRF2 transcriptional programs in NSCLC.

Main Methods:

• Utilized inducible expression of a common activating NRF2 mutation (NRF2^E79Q) in H358 (lung adenocarcinoma) and H596 (lung adeno-squamous cell carcinoma) NSCLC cell lines.
• Assessed tumor growth in both 2D cell culture and mouse xenograft models.
• Performed gene expression profiling to analyze transcriptional changes induced by NRF2 activation.

Main Results:

• NRF2^E79Q expression in H358 cells altered morphology and increased xenograft tumor growth, but not in 2D culture.
• In H596 cells, NRF2^E79Q altered morphology, increased neuroendocrine marker expression, but did not affect tumor growth in either model.
• Gene expression analysis revealed both shared and unique NRF2-driven transcriptional programs across the models, with some overlap found in primary lung tumors.

Conclusions:

• NRF2 activation exerts context-dependent effects on NSCLC cell growth and differentiation.
• NRF2 plays a role in modulating the differentiation state of human NSCLC during tumor progression.
• Findings highlight the complexity of NRF2 signaling in NSCLC and its potential as a therapeutic target.